ABACCEL
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 13 Sept 2024)
What this means for you
Registered since 12 Sept 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86970800
- Registration number
- 5283583
- Mark type
- Stylized text
- Filed
- 11 Apr 2016
- Published for opposition
- 27 Jun 2017
- Registered
- 12 Sept 2017
- Attorney of record
- Karen L. Elbing
Goods and services
- Class 042 — Scientific and technological services: Scientific and technological services and research projects for the preparation of peptide and antibody libraries, and for the identification and characterisation of binding molecules, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects for the preparation, identification and characterisation of peptides or antibodies, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects for the preparation, identification and characterisation of recombinant antibodies, single-chain antibodies, diabodies, tandabs, flexibodies, triabodies, tetrabodies, bivalent antibodies, multivalent antibodies, whole immunoglobulins, or antibody fragments, in particular Fab and scFv fragments, and of nucleic acid sequences coding for these molecules, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of natural, engineered and immunized libraries, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of antibody libraries, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to antibody development strategies, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to the optimization, maturation and humanization of antibody drug candidates, namely scientific research and analysis in the field of antibody research and drug design; scientific and technological services and research projects in relation to multi-factor antibody optimization, namely scientific research and analysis in the field of antibody research and drug design; scientific and technological services and research projects in relation to the optimization of antibody binding affinity, antibody stability, species cross-reactivity, specificity, developability, producibility, and human properties, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to human and nonhuman lead antibody technology, namely scientific research and analysis in the field of antibody research and antibody optimization
Owner
- AbCheck s.r.o., Plzen, CZ
- AbCheck s.r.o., Plzen, CZ
- AbCheck s.r.o., Plzen, CZ
Prior registrations
Prosecution history
- 13 Sept 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Sept 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Sept 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Mar 2024 — TEAS SECTION 8 & 15 RECEIVED
- 12 Sept 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 12 Sept 2017 — REGISTERED-PRINCIPAL REGISTER
- 27 Jun 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Jun 2017 — PUBLISHED FOR OPPOSITION
- 07 Jun 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 May 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Apr 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Apr 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Apr 2017 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 24 Mar 2017 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 24 Mar 2017 — FINAL REFUSAL E-MAILED